Lyons
France
43
2026-02-10
43
2026-02-10
These are the the leading inventors for applications assigned to ADOCIA:
ADOCIA based in Lyons, FR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Compositions comprising pemvidutide and an acylated amino acid
#2 | 2022-07-14 ✅ Patent 12,421,327 granted on 2025-09-23HYDROGELS FOR CELL THERAPY
#3 | 2021-12-30 ✅ Patent 12,186,373 granted on 2025-01-07Compositions in the form of an injectable aqueous solution comprising amylin, an amylin agonist receptor or an amylin analogue and a co-polyamino acid
#4 | 2021-03-04 ✅ Patent 11,324,808 granted on 2022-05-10Rapid-acting insulin formulation comprising a substituted anionic compound
#5 | 2020-12-31 ✅ Patent 11,576,952 granted on 2023-02-14Injectable solution at pH 7 comprising at least one basal insulin for which the pI is from 5.8 to 8.5 and a co-polyamino acid bearing carboxylate charges and hydrophobic radicals
#6 | 2020-10-01 ✅ Patent 11,883,496 granted on 2024-01-30Injectable pH 7 solution comprising at least one basal insulin having a pI from 5.8 to 8.5 and a co-polyamino acid bearing carboxylate charges and hydrophobic radicals
#7 | 2020-07-30 ✅ Patent 10,881,716 granted on 2021-01-05Rapid-acting insulin formulation comprising a substituted anionic compound
#8 | 2020-06-18 ✅ Patent 11,065,305 granted on 2021-07-20Compositions in the form of an injectable aqueous solution including at least human insulin A21G and a glucagon suppressor with prandial action
#9 | 2020-04-16 ✅ Patent 10,646,551 granted on 2020-05-12Rapid-acting insulin formulation comprising a substituted anionic compound
#10 | 2020-02-13 ✅ Patent 11,707,507 granted on 2023-07-25Compositions in the form of an injectable aqueous solution comprising amylin, an amylin receptor agonist or an amylin analog, and a co-polyamino acid
#11 | 2019-10-31 ✅ Patent 11,129,877 granted on 2021-09-28Compositions in the form of an injectable aqueous solution comprising amylin, an amylin agonist receptor or an amylin analogue and a co-polyamino acid
#12 | 2019-09-12 ✅ Patent 10,987,426 granted on 2021-04-27Compositions in the form of an injectable aqueous solution comprising human glucagon and a co-polyamino acid
#13 | 2019-09-12 ✅ Patent 11,633,460 granted on 2023-04-25Injectable solution at pH 7 comprising at least one basal insulin wherein the pI is comprised from 5.8 to 8.5 and a co-polyamino acid bearing carboxylate charges and hydrophobic radicals
#14 | 2019-09-12 ✅ Patent 11,191,812 granted on 2021-12-07Compositions in the form of an injectable aqueous solution comprising human glucagon and a co-polyamino acid
#15 | 2019-09-12 ✅ Patent 11,173,109 granted on 2021-11-16Compositions in the form of an injectable aqueous solution comprising amylin, an amylin receptor agonist or an amylin analog and a co-polyamino acid
#16 | 2019-02-21 ✅ Patent 10,610,572 granted on 2020-04-07Compositions in the form of an injectable aqueous solution including at least human insulin A21G and a glucagon suppressor with prandial action
#17 | 2018-08-02 ✅ Patent 10,525,133 granted on 2020-01-07Aqueous composition comprising at least one protein and one solubilizing agent, preparation thereof and uses thereof
#18 | 2018-07-12 ✅ Patent 10,463,717 granted on 2019-11-05Compositions in the form of an injectable aqueous solution comprising amylin, an amylin receptor agonist or an amylin analog, and a co-polyamino acid
#19 | 2018-06-21 ✅ Patent 10,449,256 granted on 2019-10-22Injectable solution at pH 7 comprising at least one basal insulin the isoelectric point of which is between 5.8 and 8.5 and a hydrophobized anionic polymer
#20 | 2017-12-28 ✅ Patent 10,583,175 granted on 2020-03-10Rapid-acting insulin formulation comprising a substituted anionic compound
#21 | 2017-12-07 ✅ Patent 10,383,920 granted on 2019-08-20Injectable solution at pH 7 comprising at least one basal insulin the pI of which is from 5.8 to 8.5 and a co-polyamino acid bearing carboxylate charges and hydrophobic radicals
#22 | 2017-12-07 ✅ Patent 10,548,952 granted on 2020-02-04Injectable solution at pH7 comprising at least one basal insulin the pI of which is from 5.8 to 8.5, a prandial insulin and/or a gastrointestinal hormone, and a co-polyamino acid bearing carboxylate charges and hydrophobic radicals
#23 | 2017-12-07 ✅ Patent 10,485,851 granted on 2019-11-26Compositions in the form of an injectable aqueous solution comprising human glucagon and a co-polyamino acid
#24 | 2017-12-07 ✅ Patent 10,383,918 granted on 2019-08-20Compositions in the form of an injectable aqueous solution comprising human glucagon and a statistical co-polyamino acid
#25 | 2017-05-18 ✅ Patent 10,792,335 granted on 2020-10-06Rapid-acting insulin composition comprising a substituted citrate
#26 | 2016-03-24 ✅ Patent 9,795,678 granted on 2017-10-24Fast-acting insulin composition comprising a substituted anionic compound and a polyanionic compound
#27 | 2016-03-17 ✅ Patent 10,335,489 granted on 2019-07-02Injectable solution at pH 7 comprising at least one basal insulin the pi of which is between 5.8 and 8.5 and a substituted co-polyamino acid
#28 | 2015-08-20 ✅ Patent 9,492,467 granted on 2016-11-15Rapid-acting insulin formulation comprising an oligosaccharide
#29 | 2014-12-25 ✅ Patent 9,700,599 granted on 2017-07-11Rapid-acting insulin formulation comprising a substituted anionic compound
#30 | 2014-03-13 ✅ Patent 9,457,089 granted on 2016-10-04Highly concentrated aqueous protein solution with reduced viscosity
#31 | 2014-02-13 ✅ Patent 9,278,131 granted on 2016-03-08Process for lowering the viscosity of highly concentrated protein solutions
#32 | 2013-07-11 ✅ Patent 9,198,971 granted on 2015-12-01Injectable solution at pH 7 comprising at least one basal insulin the pI of which is between 5.8 and 8.5 and a substituted co-polyamino acid
#33 | 2013-03-14 ✅ Patent 9,089,476 granted on 2015-07-28Injectable solution at pH 7 comprising at least one basal insulin whose PI is between 5.8 and 8.5
#34 | 2012-12-06 ✅ Patent 9,018,190 granted on 2015-04-28Functionalized oligosaccharides
#35 | 2011-12-08 ✅ Patent 8,241,620 granted on 2012-08-14Complex polymere amphiphile-PDGF
#36 | 2011-08-11 ✅ Patent 9,115,218 granted on 2015-08-25Anionic polysaccharides functionalized by at least two hydrophobic groups carried by an at least trivalent spacer
#37 | 2011-07-14 ✅ Patent 9,493,583 granted on 2016-11-15Anionic polysaccharides functionalized by a hydrophobic acid derivative
#38 | 2010-12-02 ✅ Patent 8,426,382 granted on 2013-04-23Polysaccharides comprising carboxyl functional groups substituted by a hydrophobic alcohol derivative
#39 | 2010-09-30 ✅ Patent 8,669,227 granted on 2014-03-11Fast-acting insulin formulation
#40 | 2010-07-22 ✅ Patent 8,367,640 granted on 2013-02-05Complex consisted of a polysaccharide and an HBP
#41 | 2010-07-01 ✅ Patent 8,497,253 granted on 2013-07-30Administration form of osteogenic protein complexes
#42 | 2009-02-19 ✅ Patent 8,389,661 granted on 2013-03-05Complexes between an amphiphilic polymer and an osteogenic protein belonging to the family of BMPs
#43 | 2008-09-25 ✅ Patent 8,629,124 granted on 2014-01-14Dextran functionalized by hydrophobic amino acids
Also check out Adocia's (Lyons, France) applicant profile with 32 patent applications submitted.
351920 ⎘